U.S. sales of morning-after pill double

Jul 13, 2007

Sales of the morning-after pill Plan B in the United States have doubled since it was made available without a prescription.

Drug maker Barr Pharmaceuticals said sales will probably be close to $80 million for 2007, The Washington Post said Friday.

The Food and Drug Administration approved the sale of the controversial emergency contraceptive without a prescription for women 18 and older last August.

Women's health and family-planning advocates say it illustrates the value of easing access to birth control to help prevent unwanted pregnancies, the newspaper said.

Conservative groups, however, question the drug's safety and maintain the pill can cause the equivalent of an abortion.

Advocates would like to see the FDA remove the age restriction.

Copyright 2007 by United Press International

Explore further: New treatment approved for rare form of hemophilia

add to favorites email to friend print save as pdf

Related Stories

Con artist who helped Google probe to be sentenced

Oct 23, 2011

(AP) -- A massive federal investigation that resulted in Google Inc. forfeiting $500 million this year to settle criminal claims over its advertising began with the 2008 arrest of a jet-setting career con artist, who took ...

30 years after first AIDS cases, hope for a cure

Jun 03, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

US aims at its deadliest drug problem: painkillers

Apr 20, 2011

(AP) -- The White House drug czar wants doctors, states and law enforcement working harder to stop America's deadliest drug-abuse problem: highly addictive prescription painkillers. They are killing more ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments : 0